LEO Pharma's topical scalp psoriasis treatment Xamiol, a gel formulation of betametasone dipropionate and calcipotriol, has been approved in 16 European countries, including France, Germany and the UK.
Xamiol will be launched in the UK in the fourth quarter of this year, with launches in other countries to...